TickerFacts.

Company research / INVA

Innoviva, Inc. (INVA)

Build a valuation ↗↓ Download CSV

CIK 0001080014 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Innoviva, Inc. reported revenue of $411.33M. Revenue grew 14.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $440.00M.

Key ratios (year ended 2025-12-31)

74.8%
Gross margin
39.8%
Operating margin
65.9%
Net margin
23.1%
Return on year-end equity
14.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-24

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$440.00M$411.33M$358.71M$310.46M$331.34M$391.87M$336.79M$261.02M$261.00M$217.22M$133.57M
Gross Profit$317.65M$307.67M$296.21M$246.04Mn/an/an/an/an/an/an/a
R&D Expense$28.66M$30.60M$13.65M$33.92M$41.43M$576.0K$1.79M$0$0$1.35M$1.39M
Operating Income$162.57M$163.75M$166.87M$113.89Mn/a$375.10M$321.12M$246.36M$238.25M$183.60M$108.99M
Depreciation & Amortizationn/an/an/an/an/a$13.83M$13.84M$13.87M$13.87M$13.98M$13.95M
EBITDAn/an/an/an/an/a$388.94M$334.96M$260.23M$252.12M$197.59M$122.94M
Net Income$357.24M$271.17M$23.39M$179.72M$220.26M$368.84M$293.81M$190.99M$406.33M$134.27M$59.54M
EPS (Diluted)n/a$3.30$0.36$2.20$2.37$2.87$2.02$1.43$3.53$1.17$0.53
Total Assets$1.70B$1.64B$1.30B$1.24B$1.23B$926.39M$999.57M$724.83M$548.19M$367.34M$379.00M
Shareholders' Equity$1.23B$1.17B$691.16Mn/a$565.79M$414.74M$539.91M$313.50M$153.58M-$242.86M-$352.99M
Cash & Equivalents$570.39M$550.94M$304.96M$193.51M$291.05M$201.53M$246.49M$278.10M$62.42M$73.34M$118.02M
Operating Cash Flow$191.49M$196.93M$188.69M$141.06M$201.73M$363.81M$313.11M$257.46M$223.53M$141.75M$60.98M
Capital Expenditures$2.05M$1.13M$270.0K$411.0K$67.0K$0$13.0K$12.0K$0$0$278.0K
Free Cash Flow$189.44M$195.80M$188.42M$140.65M$201.66M$363.81M$313.10M$257.45M$223.53M$141.75M$60.71M
Share Repurchases$55.85M$4.53M$14.78M$75.73M$8.50M$394.15M$0$0$0$97.50M$78.09M
Dividends Paidn/an/an/an/an/a$0$0$11.0K$80.0K$281.0K$960.0K
Shares Outstanding72.64M74.64M62.66M63.31M69.19M69.57M101.39M101.29M101.10Mn/an/a
Dividends Per Sharen/an/an/an/an/an/an/an/an/a$0.00$0.00
Weighted Average Diluted Sharesn/a84.76M74.19M86.88M95.25M94.31M113.55M113.41M113.41M119.87M123.23M
EPS (Basic)n/a$4.02$0.37$2.75$3.07$3.24$2.21$1.55$3.92$1.25$0.54

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView